Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

Study finds tracking tools too challenging for elderly, those with multiple conditions

If providers want the elderly and those with chronic conditions to adopt mobile health tools, developers will need to make the tools more convenient and easier to use, according to a study published in the Journal of Medical Internet Research.

New innovation hub, public-private collaboration to focus on apps, wearables

The Obama administration will award a Manufacturing Innovation Institute for Flexible Hybrid Electronics to a consortium of 162 companies, universities and non-profits led by the FlexTech Alliance, according to an announcement from the Department of Defense.

Thumbnail

Electronic triggers yield speedier cancer diagnosis

Electronic triggers designed to search for key data were able to identify and reduce follow-up delays for patients being evaluated for a diagnosis of colon or prostate cancer.

Thumbnail

Medicare ACOs slow to earn saving bonuses

Although Medicare's 20 Pioneer and 333 Shared Savings Program accountable care organizations (ACOs) generated more than $411 million in savings in 2014, three out of four of these ACOs did not slow health spending enough to earn bonuses last year.

Obama's Precision Medicine Initiative seeks submissions to further vision

In a follow-up to the February announcement of the Obama Administration’s Precision Medicine Initiative, the White House posted a blog post seeking contributions that further the initiative’s goals.

Thumbnail

Unconscious biases are common in healthcare

The Association of American Medical Colleges recently launched a training program where it trains faculty members and physicians to examine their unconscious biases.

Accenture, Duke launch analytics research partnership

Accenture and Duke University have formed an alliance focused on jointly developing new advanced analytics solutions. 

Thumbnail

Three exciting new initiatives

This week in health IT, there were several partnerships announced that aim to advance healthcare. While there is much wrong with the state of healthcare today, these are the kinds of initiatives that signal an exciting future.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.